Locally recurrent rectal cancer: oncological outcomes of neoadjuvant chemoradiotherapy with or without induction chemotherapy

Br J Surg. 2023 Nov 9;110(12):1637-1640. doi: 10.1093/bjs/znad214.

Authors

Stefi Nordkamp^{1

2}, Jan M van Rees³, Kim van den Berg^{2

4}, David M Mens³, Davy M J Creemers¹, Heike M U Peulen⁵, Geert-Jan Creemers⁴, Grard A P Nieuwenhuijzen¹, Jip L Tolenaar¹, Johanne G Bloemen¹, Joost Rothbarth³, Harm J T Rutten^{1

2}, Cornelis Verhoef³, Jacobus W A Burger¹

Affiliations

¹ Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
² GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands.
³ Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
⁴ Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.
⁵ Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands.

PMID: 37406084
DOI: 10.1093/bjs/znad214

No abstract available

MeSH terms

Chemoradiotherapy
Humans
Induction Chemotherapy
Neoadjuvant Therapy*
Neoplasm Recurrence, Local / pathology
Neoplasm Staging
Rectal Neoplasms* / pathology
Rectum / pathology
Treatment Outcome